Search research articles
Contact Us
Filters
Showing results (41-50 of 51) with videos related to
Page
of 6
Sort By:
British Journal of Cancer
|
April 9, 2020
Covariate-adjusted analysis of the Phase 3 REFLECT study of lenvatinib versus sorafenib in the treatment of unresectable hepatocellular carcinoma
Andrew Briggs, Bruno Daniele, Katherine Dick, et al.
Future Oncology (London, England)
|
March 2, 2022
Effectiveness of crizotinib versus entrectinib in <i>ROS1</i>-positive non-small-cell lung cancer using clinical and real-world data
Gabriel Tremblay, Michael Groff, Laura Iadeluca, et al.
Patient Preference and Adherence
|
November 26, 2015
Health state utility valuation in radioactive iodine-refractory differentiated thyroid cancer
Beth A Fordham, Cicely Kerr, Hayley M de Freitas, et al.
Journal of Medical Internet Research
|
August 1, 2023
Economic Evaluation Associated With Clinical-Grade Mobile App-Based Digital Therapeutic Interventions: Systematic Review
Yoann Sapanel, Xavier Tadeo, Connor T A Brenna, et al.
BMC Cancer
|
April 29, 2024
Progression-free survival as a surrogate endpoint for overall survival in patients with relapsed or refractory multiple myeloma
Meletios Dimopoulos, Pieter Sonneveld, Salomon Manier, et al.
Journal of Medical Economics
|
July 22, 2024
Population health outcomes of blood-based screening for colorectal cancer in comparison to current screening modalities: insights from a discrete-event simulation model incorporating longitudinal adherence
Shaun P Forbes, Elifnur Yay Donderici, Nicole Zhang, et al.
Pharmacoeconomics
|
July 2, 2024
Cost-Effectiveness of Plasma Microbial Cell-Free DNA Sequencing When Added to Usual Care Diagnostic Testing for Immunocompromised Host Pneumonia
Andrew J Sutton, Daniel S Lupu, Stephen P Bergin, et al.
JAMA Network Open
|
July 12, 2022
Economic Evaluation of Cost and Time Required for a Platform Trial vs Conventional Trials
Jay J H Park, Behnam Sharif, Ofir Harari, et al.
Frontiers in Pain Research (Lausanne, Switzerland)
|
February 16, 2026
Barriers and facilitators to implementing immersive virtual reality in long-term care settings: an interdisciplinary partnership study exploring staff perspectives
Isabel Sadowski, Mael Gagnon-Mailhot, Gbeada Josiane Seu, et al.
Future Oncology (London, England)
|
February 2, 2021
Health-related quality of life and utility outcomes with selinexor in relapsed/refractory diffuse large B-cell lymphoma
Jatin Shah, Sharon Shacham, Michael Kauffman, et al.
Page
of 6
Search research articles
Search
Showing results (41-50 of 51) with videos related to
Sort By:
Page
of 6
British Journal of Cancer
|
April 9, 2020
Covariate-adjusted analysis of the Phase 3 REFLECT study of lenvatinib versus sorafenib in the treatment of unresectable hepatocellular carcinoma
Andrew Briggs, Bruno Daniele, Katherine Dick, et al.
Future Oncology (London, England)
|
March 2, 2022
Effectiveness of crizotinib versus entrectinib in <i>ROS1</i>-positive non-small-cell lung cancer using clinical and real-world data
Gabriel Tremblay, Michael Groff, Laura Iadeluca, et al.
Patient Preference and Adherence
|
November 26, 2015
Health state utility valuation in radioactive iodine-refractory differentiated thyroid cancer
Beth A Fordham, Cicely Kerr, Hayley M de Freitas, et al.
Journal of Medical Internet Research
|
August 1, 2023
Economic Evaluation Associated With Clinical-Grade Mobile App-Based Digital Therapeutic Interventions: Systematic Review
Yoann Sapanel, Xavier Tadeo, Connor T A Brenna, et al.
BMC Cancer
|
April 29, 2024
Progression-free survival as a surrogate endpoint for overall survival in patients with relapsed or refractory multiple myeloma
Meletios Dimopoulos, Pieter Sonneveld, Salomon Manier, et al.
Journal of Medical Economics
|
July 22, 2024
Population health outcomes of blood-based screening for colorectal cancer in comparison to current screening modalities: insights from a discrete-event simulation model incorporating longitudinal adherence
Shaun P Forbes, Elifnur Yay Donderici, Nicole Zhang, et al.
Pharmacoeconomics
|
July 2, 2024
Cost-Effectiveness of Plasma Microbial Cell-Free DNA Sequencing When Added to Usual Care Diagnostic Testing for Immunocompromised Host Pneumonia
Andrew J Sutton, Daniel S Lupu, Stephen P Bergin, et al.
JAMA Network Open
|
July 12, 2022
Economic Evaluation of Cost and Time Required for a Platform Trial vs Conventional Trials
Jay J H Park, Behnam Sharif, Ofir Harari, et al.
Frontiers in Pain Research (Lausanne, Switzerland)
|
February 16, 2026
Barriers and facilitators to implementing immersive virtual reality in long-term care settings: an interdisciplinary partnership study exploring staff perspectives
Isabel Sadowski, Mael Gagnon-Mailhot, Gbeada Josiane Seu, et al.
Future Oncology (London, England)
|
February 2, 2021
Health-related quality of life and utility outcomes with selinexor in relapsed/refractory diffuse large B-cell lymphoma
Jatin Shah, Sharon Shacham, Michael Kauffman, et al.
Page
of 6